• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

India to assess side effects of COVID-19 vaccine

expresspharmaApril 12, 2021

Tag: India , COVID-19 vaccine , side effect , blood clot

A panel of Indian experts is investigating if there are any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in the country, reported Mint, a financial newspaper.

India is currently administering AstraZeneca’s COVID-19 vaccine and a shot developed at home by Bharat Biotech.

Several countries in Europe have announced restrictions on the use of the AstraZeneca vaccine in younger people, after a link was found to very rare blood clots, mostly in women under 60 years of age within two weeks of vaccination.

Previous:Remdesivir’s price must not be more than Rs 1400 per vial: Maha Health Minister

Next:Biogen and Bio-Thera enter licencing agreement for arthritis biosimilar

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

India to assess side effects of COVID-19 vaccine | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Factory Free Sample Bulk Food Pure Grade Natural India Herbal Plant Extract Madder Root Extract

Factory Free Sample Bulk Food Pure Grade Natural India Herbal Plant Extract Madder Root Extract
Mifepristone (INDIA DMF)

Mifepristone (INDIA DMF)
Top Quality Indian Bread P.E.

Top Quality Indian Bread P.E.
100% Pure Freeze Dried Black Berry Anthocyanin Juice Indian Instant Fruit Blackberry Powder

100% Pure Freeze Dried Black Berry Anthocyanin Juice Indian Instant Fruit Blackberry Powder
Evening Primrose Oil (OEM/ODM) | Evening Primrose Oil From India / natural Evening Prim rose Oil

Evening Primrose Oil (OEM/ODM) | Evening Primrose Oil From India / natural Evening Prim rose Oil

Indian Trum etflower Seed Extract

Indian Trum etflower Seed Extract

PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL
GENTAMYCIN SULPHATE macrolides

GENTAMYCIN SULPHATE macrolides
CEFALEXINE cephalosporins

CEFALEXINE cephalosporins

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service